NIH-funded research R01 grant

AI tools to improve checks of radiation therapy plans

Official title: Development of AI-Augmented quality assurance tools for radiation therapy

Funded at Stanford University · NIH-11289312 · Data updated 2026-11-12

Using artificial intelligence to speed up and strengthen safety checks of radiation treatment plans for people getting external beam radiotherapy.

More Radiation Therapy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2028
Funding year2026
Award (this year)$506,276
NIH project number5R01CA275772-04
Project IDNIH-11289312 on NIH RePORTER

Who could benefit from this research

Could help

People receiving external beam radiation therapy (especially IMRT/VMAT) at participating clinics, whose treatment plans and imaging can be reviewed, would be the ideal candidates.

Less likely to help

Patients not receiving external beam photon therapy (for example those only receiving brachytherapy or other non‑photon treatments) may not benefit from these specific tools.

What this research studies

This project will build AI (deep learning) tools that automatically check radiation treatment plans before you are treated. The tools will read the planned machine settings (like multileaf collimator shapes and monitor units) and predict the 3‑D dose on your treatment CT to look for mismatches or errors. The system will also cross‑check by translating predicted dose back into machine parameters to catch inconsistencies. The goal is a faster, more reliable QA step that could fit into routine clinic workflows.

Why it matters

Potential benefit: If successful, this could make radiation therapy safer and less prone to delays by catching planning or delivery problems earlier and reducing manual QA work.

How similar studies have gone: Some AI methods have shown promise for parts of radiation QA, but this project’s combined machine‑parameter and 3‑D dose cycle‑consistency approach is a novel, first‑of‑its‑kind effort.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Xing, Lei — Stanford University
  • Study coordinator: Xing, Lei

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.